Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACALABRUTINIB vs ACECLOFENAC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACALABRUTINIB vs ACECLOFENAC: Safety Overview

Metric ACALABRUTINIB ACECLOFENAC
Total FAERS Reports 9,688 500
Deaths Reported 2,239 281
Death Rate 23.1% 56.2%
Hospitalizations 2,441 119
Average Patient Age 73.2 yrs 54.5 yrs
% Female Patients 36.8% 57.6%
FDA Approval Date Aug 3, 2022 N/A
Manufacturer AstraZeneca Pharmaceuticals LP N/A
Route ORAL N/A
Marketing Status Prescription N/A